Ouabain protects against shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL

Journal of the American Society of Nephrology

Volumn 24, Issue 9, 2013, Pages 1413-1423

  Burlaka, Ievgeniia ^a   Liu, Xiao Li ^a   Rebetz, Johan ^b   Arvidsson, Ida ^b   Yang, Liping ^c   Brismar, Hjalmar ^d   Karpman, Diana ^b   Aperia, Anita ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c NANTONG UNIVERSITY   (China)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; HELENALIN; OUABAIN; PROTEIN BAX; PROTEIN BCL XL; SHIGA TOXIN; TRANSCRIPTION FACTOR RELA; VEROTOXIN 2; VIRULENCE FACTOR;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GASTROINTESTINAL INFECTION; HEMOLYTIC UREMIC SYNDROME; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; MALE; MINIPUMP; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SIGNAL TRANSDUCTION; TOXIN ANALYSIS;

EID: 84884297830     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012101044     Document Type: Article

References (39)

1. Obrig TG: Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) 2: 2769-2794, 2010
2. Karpman D, Sartz L, Johnson S: Pathophysiology of typical hemolytic uremic syndrome. Semin Thromb Hemost 36: 575-585, 2010
3. Bergan J, Dyve Lingelem AB, Simm R, Skotland T, Sandvig K: Shiga toxins. Toxicon 60: 1085-1107, 2012
4. Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG: Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 77: 959-969, 2009
5. Karpman D, Håkansson A, PerezMT, Isaksson C, CarlemalmE, Caprioli A, Svanborg C: Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66: 636-644, 1998
6. Fujii J,Wood K,Matsuda F, Carneiro-Filho BA, Schlegel KH, Yutsudo T, Binnington-Boyd B, Lingwood CA, Obata F, Kim KS, Yoshida S, Obrig T: Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun 76: 3679-3689, 2008
7. Lee SY, Cherla RP, Caliskan I, Tesh VL: Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor receptor-independent mechanism. Infect Immun 73: 5115-5126, 2005
8. Taylor RC, Cullen SP,Martin SJ: Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241, 2008
9. Schinzel A, Kaufmann T, Borner C: Bcl-2 family members: Intracellular targeting, membrane-insertion, and changes in subcellular localization. Biochim Biophys Acta 1644: 95-105, 2004
10. Gordon J, Challa A, Levens JM,Gregory CD, Williams JM, Armitage RJ, Cook JP, Roberts LM, Lord JM: CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin. Cell Death Differ 7: 785-794, 2000
11. Jones NL, Islur A, Haq R, Mascarenhas M, Karmali MA, Perdue MH, Zanke BW, Sherman FM: Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. AJP GI 278: 811-819, 2000
12. Bitzan M, Schaefer F, Reymond D: Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost 36: 594-610, 2010
13. Boyer O, Niaudet P: Hemolytic uremic syndrome: New developments in pathogenesis and treatment. Int J Nephrol 2011: 908407, 2011
14. Aperia A: New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. J Intern Med 261: 44-52, 2007
15. Zhang S, Malmersjö S, Li J, Ando H, Aizman O, Uhlén P, Mikoshiba K, Aperia A: Distinct role of the N-terminal tail of the Na,K-ATPase catalytic subunit as a signal transducer. J Biol Chem281: 21954-21962, 2006
16. Miyakawa-Naito A, Uhlén P, Lal M, Aizman O, Mikoshiba K, Brismar H, Zelenin S, Aperia A: Cell signalingmicrodomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. J Biol Chem278: 50355-50361, 2003
17. Aizman O, Uhlén P, Lal M, Brismar H, Aperia A: Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc Natl Acad Sci U S A 98: 13420-13424, 2001
18. Li J, Zelenin S, Aperia A, Aizman O: Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activationofNF-kappaB.JAmSocNephrol 17: 1848-1857, 2006
19. Li J, KhodusGR,Markus KruusmägiM, Kamali-Zare P, Liu X, Eklöf A-Ch, Zelenin S, Brismar H, Aperia A. Ouabain protects against adverse developmental programming of the kidney. Nature Communications 27, 2010.
20. Tamatani M, Che YH, Matsuzaoki H, Ogawa S, Okado H, Miyake S, Mizuno T, Tohyama M: Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem274: 8531-8538, 1999
21. Keepers TR, Psotka MA, Gross LK, Obrig TG: A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17: 3404-3414, 2006
22. Dahiya R, Brasitus TA: Dexamethasone-induced alterations in the glycosphingolipids of rat kidney. Lipids 23: 863-868, 1988
23. Lindberg AA, Brown JE, Strömberg N, Westling-Ryd M, Schultz JE, Karlsson KA: Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type. J Biol Chem 5;262: 1779-1785, 1987
24. Sarnico I, Lanzillotta A, Benarese M, Alghisi M, Baiguera C, Battistin L, Spano P, Pizzi M: NF-kappaB dimers in the regulation of neuronal survival. Int Rev Neurobiol 85: 351-362, 2009
25. Lyss G, Knorre A, Schmidt TJ, Pahl HL,Merfort I: The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NFkappaB by directly targeting p65 J Biol Che 11: 273(50): 33508-335016, 1998.
26. LyßG, Knorre A, Schmidt TJ, Pahl HL,Merfort I: The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NFkB by directly targeting p65. J Biol Chem 273: 50: 33508-33516, 1998
27. Gustafsson AB, Gottlieb RA: Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 292: C45-C51, 2007
28. Sauter KAD,Melton-Celsa AR, Larkin K, TroxellML,O'Brien AD,Magun BE:Mouse model of hemolytic-uremic syndrome caused by endotoxinfree Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Infect Immun 76: 4469-4478, 2008
29. Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol 35: 495-516, 2007
30. Kroemer G, Galluzzi L, Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007
31. Tironi-Farinati C, Loidl CF, Boccoli J, Parma Y, Fernandez-Miyakawa ME, Goldstein J: Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities. J Neuroimmunol 222: 48-61, 2010
32. Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nel AE: The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol 165: 1743-1754, 2000
33. Pavenstädt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003
34. Sanchez-Niño MD, Bozic M, Córdoba-Lanús E, Valcheva P, Gracia O, Ibarz M, Fernandez E, Navarro-Gonzalez JF, Ortiz A, Valdivielso JM: Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol 15; 302: 647-657, 2012
35. Sanchez-Niño MD, Sanz AB, Lorz C, Gnirke A, Rastaldi MP, Nair V, Egido J, Ruiz-Ortega M, Kretzler M, OrtizA: BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol 21: 610-621, 2010
36. Chevalier RL, Forbes MS: Generation and evolution of atubular glomeruli in theprogressionof renaldisorders. JAmSocNephrol 19: 197-206, 2008
37. Ostrom L, Tang MJ, Gruss P, Dressler GR: Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease. Dev Biol 219: 250-258, 2000
38. SrichaiMB, Hao C, Davis L, Golovin A, ZhaoM,Moeckel G, Dunn S, Bulus N, Harris RC, Zent R, Breyer MD: Apoptosis of the thick ascending limb results in acute kidney injury. J Am Soc Nephrol 19: 1538-1546, 2008
39. SanzAB, Santamaría B, Ruiz-OrtegaM,Egido J,OrtizA:Mechanismsof renal apoptosis in health and disease. J AmSocNephrol 19: 1634-1642, 2008